• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

In vitro and in vivo effects of Peganum harmala L. seeds extract against influenza A virus

tetano

Editor, Senior Moderator
Avicenna J Phytomed. 2017 Nov-Dec;7(6):519-530.
[h=1]In vitro and in vivo effects of Peganum harmala L. seeds extract against influenza A virus.[/h] Moradi MT[SUP]1[/SUP], Karimi A[SUP]2[/SUP], Fotouhi F[SUP]3[/SUP], Kheiri S[SUP]4[/SUP], Torabi A[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Objective:[/h] Influenza A virus infections are still a major health problem and the choices available for the control and treatment of the disease are limited. This research evaluated in vitro and in vivo antiviral effects of Peganum harmala L. seeds (PHS) extract against influenza A virus.
[h=4]Materials and Methods:[/h] In this research, in vitro anti-influenza A virus activity of the extract was assessed in Madin-Darby canine kidney (MDCK) cells. In order to evaluate anti-influenza activity of PHS extract in vivo, BALB/c mice were infected with 5LD[SUB]50[/SUB] of mouse-adapted influenza virus (H1N1; PR8) and received 200 mg/kg/day of PHS extract or 20 mg/kg/day oseltamivir. Lungs of seven mice per group were removed on day 3 post-infection and lung virus titers were determined by qRT-PCR. Mice survival, body weights and general conditions were observed for up to 14 days post-infection.
[h=4]Results:[/h] The results demonstrated that, the ethanolic extract of PHS possesses high activity against influenza virus with IC[SUB]50[/SUB] value of 15.7 (CI95%:11.7-21) μg/ml in MDCK cells. Our results also showed that, oral administration of PHS extract (200 mg/kg/day) or oseltamivir (20 mg/kg/day) to infected mice, increased the survival rate, reduced body weight loss, and decreased lung virus titer.
[h=4]Conclusion:[/h] Based on our findings, P. harmala seeds extract can inhibit influenza A virus replication in vitro and in vivo. Therefore, isolation and characterization of the plant's active compounds and investigation of the underlying mechanisms of its antiviral action are highly suggested.


[h=4]KEYWORDS:[/h] Antiviral activity; Influenza A virus; Peganum harmala L.

PMID: 29299435
 
Back
Top Bottom